| 摘要 |
It is intended to provide a mitochondria activator which contains as the active ingredient pyrroloquinoline quinone preferably together with coenzyme Q (in particular, reduced coenzyme Q); and a mitochondria activator which contains as the active ingredient citric acid preferably together with coenzyme Q (in particular, reduced coenzyme Q). Pyrroloquinoline quinone or citric acid and coenzyme Q (in particular, reduced coenzyme Q) exert a synergistic effect of activating mitochondria and this effect can be obtained at a high level even in a low dose. Thus, mitochondria activators having an improved safety and being useful in practice can be provided. It is also intended to provide drugs for preventing or treating diseases caused by mitochondrial dysfunction.
|
